Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period

Document ID: FDA-2006-D-0356-0004
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E8-21197
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NEC-Notice of Extension
Received Date: September 10 2008, at 08:09 AM Eastern Daylight Time
Start-End Page: 52861 - 52862
Page Count: 2
Comment Start Date: September 11 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: October 14 2008, at 11:59 PM Eastern Standard Time

Comments

   
Total: 3
DuPont BioMedical (DuPont) - Comment
Posted: 10/10/2008     ID: FDA-2006-D-0356-0005

Oct 14,2008 11:59 PM ET
DuVal & Associates, P.A. - Comment
Posted: 10/15/2008     ID: FDA-2006-D-0356-0006

Oct 14,2008 11:59 PM ET
Ethicon, Inc. - Comment
Posted: 10/16/2008     ID: FDA-2006-D-0356-0007

Oct 14,2008 11:59 PM ET

Related Documents

Total: 0
No documents available.